| Use of CFTR modulators in special populations, part 1: pregnancy and lactation J Elijah, LJ Fitzgerald, H Phan Pediatric Pulmonology 58 (12), 3377-3385, 2023 | 7 | 2023 |
| Use of CFTR modulators in special populations, part 3: Solid organ transplant NK Kadouh, J Elijah, LJ Fitzgerald, H Phan Pediatric Pulmonology 58 (12), 3393-3402, 2023 | 4 | 2023 |
| Use of CFTR modulators in special populations, part 2: Severe lung disease J Elijah, LJ Fitzgerald, H Phan Pediatric Pulmonology 58 (12), 3386-3392, 2023 | 4 | 2023 |
| Real-world Outcomes of Sacituzumab Govitecan in Metastatic Breast Cancer Patients: A Single Institution Experience S Alaklabi, J Elijah, A Mariam Roy, A Groman, S Gandhi Miami Breast Cancer Conference Abstracts Supplement 37 (4), 9-10, 2023 | 2 | 2023 |
| Evaluation of biliary toxicity in patients with hepatic artery infusion pumps J Elijah, AJ Schepers, JC Krauss, RL McDevitt Journal of Oncology Pharmacy Practice 29 (8), 1915-1920, 2023 | 1 | 2023 |
| The Efficacy of Capsaicin on Sleep Quality and Fatigue in Fibromyalgia J Elijah, K Powell, MA Smith Journal of Pain & Palliative Care Pharmacotherapy 36 (2), 112-116, 2022 | 1 | 2022 |
| Real-World Clinical Outcomes With Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer S Alaklabi, AM Roy, P Zagami, A Chakraborty, N Held, J Elijah, A George, ... JCO Oncology Practice, OP. 24.00242, 2024 | | 2024 |
| Trilaciclib use in extensive-stage small cell lung cancer (ES-SCLC): are clinical benefits seen in the real-world setting? J Elijah, P Jain, A Holdsworth, J Baron, E Przespolewski, K Wang, ... Supportive Care in Cancer 32 (9), 622, 2024 | | 2024 |
| Evaluation of safety outcomes between nivolumab regimens with differing dosing patterns J Elijah, I Puzanov, B Cresanti, L Hamad, K Attwood, K Catalfamo, ... Journal of Oncology Pharmacy Practice, 10781552241264817, 2024 | | 2024 |
| Real world outcomes of trilaciclib in ES-SCLC. J Elijah, A Holdsworth, K Wang, K Attwood, J Baron, E Przespolewski, ... Journal of Clinical Oncology 41 (16_suppl), e20637-e20637, 2023 | | 2023 |
